Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Study Evaluating Zipalertinib with Chemotherapy for Lung Cancer Patients with Uncommon EGFR Mutations After Surgery Recruiting

2025-521775-31-00 Stage IB-IIIA NSCLC Patients with uncommon EGFR Mutatio 5 2025-11-12
Randomized phase 2 study of Simvastatin in patients with ARID1A mutated advanced gastrooesophageal carcinoma treated with Nivolumab and Oxal… Recruiting

2024-519591-39-00 advanced or metastatic gastrooesophageal carcinoma HER2 4 2025-11-11
The IPa-Gastric trial: Comparing Intraperitoneal Paclitaxel and Systemic Therapy versus Systemic Therapy alone in Gastric Cancer Patients wi… Recruiting

2024-514879-17-00 Gastric cancer 5 2025-11-05
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor (BTKi) and a Bcell Lymphoma-2 Inhibit… Recruiting

2025-521088-10-00 Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia 4 2025-10-23
An Open-label, Randomized, Phase 3 Study to Evaluate Patritumab Deruxtecan Monotherapy versus Treatment of Physician’s Choice in Hormone Rec… Recruiting

2025-520582-51-00 Hormone receptor positive breast cancer 5 2025-10-17
A Phase 3 Single-arm Study of UGN-104 for the Treatment of LG-UTUC Recruiting

2024-519343-15-00 Low-grade Upper Tract Urothelial Cancer 5 2025-10-08
A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab vs Chemotherapy plus Pembrolizumab as First-Line Treatment o… Recruiting

2023-508056-19-00 HER2-Expressing (IHC 3+/IHC 2+), Mismatch Repair Profi 5 2025-10-02
Phase 3 Study of T-DXd and Rilvegostomig versus Standard of Care in Advanced HER2-expressing Biliary Tract Cancer Recruiting

2023-508057-19-00 Advanced HER2-expressing Biliary Tract Cancer 5 2025-09-23
Clinical study of ruxolitinib and venetoclax for children with relapsed or refractory leukemia or lymphoma with mutations in the IL-7R/JAK-S… Recruiting

2022-501867-42-01 Acute Lymphoblastic Leukemia, in Relapse Lymphoblastic 9 2025-09-08
An Early Phase Clinical Trial to Evaluate COM701 in Relapsed Platinum Sensitive Ovarian Cancer (PSOC) Recruiting

2025-521125-33-00 Ovarian Cancer 9 2025-09-05
A study to compare pharmacokinetics, efficacy, safety, and immunogenicity of MB12 (proposed pembrolizumab biosimilar) to Keytruda® in non-sm… Recruiting

2024-515853-48-00 advanced/metastatic non-squamous non-small cell lung ca 5 2025-09-05
Osimertinib plus chemotherapy as 1st line therapy in stage IV NSCLC patients with atypical EGFR mutations (AIO-TRK/YMO-0324) Recruiting

2024-516790-78-00 stage IV NSCLC (non-small-cell lung cancer) 4 2025-09-04
Medical-scientific study of dasatinib and venetoclax for children with relapsed or refractory leukemia or lymphoma with a mutation in the MA… Recruiting

2022-501866-22-00 Acute Lymphoblastic Leukemia, in Relapse Lymphoblastic 9 2025-08-26
A clinical study of treatments for non-small cell lung cancer (MK-3475-01I) Recruiting

2024-518839-11-00 Stage IV Squamous Non-Small Cell Lung Cancer 4 2025-08-25
A Worldwide Study Testing the New Drug Lisaftoclax for Patients with Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma… Recruiting

2024-514084-26-00 Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymp 5 2025-08-22
A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia … Recruiting

2024-512753-24-00 Acute Myeloid Leukemia (AML) 5 2025-08-05
A Study of YL201 in Patients With Advanced Solid Tumors Recruiting

2024-517589-41-00 Advanced solid tumors 1 2025-08-04
ImmunotherApy for the Prevention of High-Risk Oral DIsorders malignanT transformation - APHRODITE trial Recruiting

2025-521490-13-00 Oral disorders 4 2025-07-30
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult P… Recruiting

2023-505479-56-00 Follicular lymphoma (FL) 1 2025-07-30
A Phase 1, Open-Label Dose Escalation and Expansion study of SNV1521 in Participants with Advanced Solid Tumors Recruiting

2025-520557-36-00 Advanced Solid Tumors 1 2025-07-24
A study to determine how safe MB-CART2019.1 is and how well it works in children and adolescents with B cell neoplasms Recruiting

2023-506348-17-00 Relapsed/refractory (r/r) mature B cell neoplasms who h 4 2025-07-22
A phase 2 placebo-controlled trial to investigate visugromab in combination with immunochemotherapy (ICT) in first-line treatment of partici… Recruiting

2024-516792-32-01 Metastatic non-squamous non-small cell lung cancer 4 2025-07-18
Neoadjuvant Tebentafusp in Patients with Metastatic Uveal Melanoma Recruiting

2023-509076-42-00 Metastatic uveal melanoma with resectable liver metasta 4 2025-07-18
BOLD-100 in Combination with FOLFOX for the Treatment of Advanced Solid Tumours Recruiting

2024-517500-11-00 Colorectal Cancer 7 2025-07-15